Annual EPS
$3.66$2.07+130.33%
Summary
- Current Value
- As of today, GSK annual EPS is $3.66, up +130.33% on
- Historical Performance
- GSK annual EPS is down -59.44% over the past 3 years, up +0.03% over the past 5 years
- All-Time High Comparison
- GSK annual EPS is currently -59.44% below its historical high of $9.02 set on
- 3-Year Low Comparison
- GSK annual EPS is +130.33% above its 3-year low of $1.59 reached on
- Sector Comparison
- GSK annual EPS is higher than 93.70% of companies in Healthcare sector
- Analyst Estimate
- Analysts estimate GSK annual EPS at $4.84, +32.29% higher than the current value
- Upcoming Earnings
- As of today, the next annual earnings release for GSK has not been scheduled
EPS Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EPS | $3.66 | +130.3% | -59.4% | +0.0% | +197.3% | |
| Quarterly EPS | $1.15 | +16.2% | +29.6% | +56.5% | -3.1% | |
| TTM EPS | $3.82 | +98.5% | -55.0% | +13.4% | +169.9% | |
| Price | $50.67 | +31.1% | +44.1% | +24.7% | +20.2% | |
| Annual Revenue | $43.05B | +7.4% | +19.2% | -1.5% | -1.8% | |
| PE Ratio | 13.25 | -34.0% | +220.1% | +10.1% | -55.5% | |
| Annual Net Income | $8.29B | +119.8% | +36.7% | +1.2% | +189.8% | |
| Annual Gross Profit | $30.76B | +9.9% | +28.3% | +3.8% | -3.6% | |
| Shares Outstanding | 2.00B | -1.9% | -1.1% | +0.1% | – |
EPS Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $9.02 | N/A | -59.4% |
| 5Y | $9.02 | -59.4% | |
| All | $9.02 | -59.4% |
EPS Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $1.59 | +130.3% | |
| 5Y | $1.59 | +130.3% | |
| All | $0.63 | +484.8% |
EPS Estimates
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $3.92 | $1.59 | -59.44% | |
| $4.50 | $3.66 | -18.72% | |
| $4.84 | N/A | +32.29% | |
| $5.23 | N/A | +42.95% |
🔒 Log In To Unlock Full Data
EPS History
FAQ
What is the current annual EPS of GSK?
As of today, GSK annual EPS is $3.66
What is 1-year change in GSK annual EPS?
GSK annual EPS is up +130.33% year-over-year
What is 3-year change in GSK annual EPS?
GSK annual EPS is down -59.44% over the past 3 years
How far is GSK annual EPS from its all-time high?
GSK annual EPS is currently -59.44% below its historical high of $9.02 set on December 31, 2022
How does GSK annual EPS rank versus sector peers?
GSK annual EPS is higher than 93.70% of companies in Healthcare sector
How does the analyst estimate for GSK annual EPS compare to its current value?
Analysts estimate GSK annual EPS at $4.84, +32.29% higher than the current value
When is GSK next annual earnings release?
As of today, the next annual earnings release for GSK has not been scheduled
EPS Formula
EPS =
Quarterly EPS
$1.15$0.73+177.51%
Summary
- Current Value
- As of today, GSK quarterly EPS is $1.15, up +177.51% on
- Historical Performance
- GSK quarterly EPS is up +16.20% year-over-year, up +29.61% over the past 3 years
- All-Time High Comparison
- GSK quarterly EPS is currently -81.72% below its historical high of $6.28 set on
- 3-Year Low Comparison
- GSK quarterly EPS is +3205.14% above its 3-year low of -$0.04 reached on
- Sector Comparison
- GSK quarterly EPS is higher than 93.14% of companies in Healthcare sector
- Analyst Estimate
- Analysts estimate GSK quarterly EPS at $1.25, +8.62% higher than the current value
- Upcoming Earnings
- The next earnings release for GSK is on
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EPS | $1.15 | +177.5% | +16.2% | +29.6% | +56.5% | |
| Annual EPS | $3.66 | – | +130.3% | -59.4% | +0.0% | |
| TTM EPS | $3.82 | +4.4% | +98.5% | -55.0% | +13.4% | |
| Price | $50.67 | -2.7% | +31.1% | +44.1% | +24.7% | |
| Quarterly Revenue | $10.28B | -10.3% | +8.6% | +21.7% | +0.5% | |
| PE Ratio | 13.25 | -6.8% | -34.0% | +220.1% | +10.1% | |
| Quarterly Net Income | $2.48B | +156.3% | +11.0% | +25.0% | +42.6% | |
| Quarterly Gross Profit | $7.76B | -2.5% | +10.2% | +26.6% | +13.1% | |
| Shares Outstanding | 2.00B | – | -1.9% | -1.1% | +0.1% |
Quarterly EPS Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.32 | -13.2% | |
| 3Y | $1.32 | -13.2% | |
| 5Y | $6.23 | -81.5% | |
| All | $6.28 | -81.7% |
Quarterly EPS Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $0.41 | +177.5% | |
| 3Y | -$0.04 | +3205.1% | |
| 5Y | -$0.04 | +3205.1% | |
| All | -$0.53 | +317.9% |
Quarterly EPS Estimates
| Month | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $0.62 | $0.41 | -33.65% | |
| $1.16 | $1.15 | -1.32% | |
| $1.25 | N/A | +8.62% | |
| $1.44 | N/A | +25.37% |
🔒 Log In To Unlock Full Data
Quarterly EPS History
FAQ
What is the current quarterly EPS of GSK?
As of today, GSK quarterly EPS is $1.15
What is GSK quarterly EPS most recent change?
GSK quarterly EPS was up +177.51% on March 31, 2026
What is 1-year change in GSK quarterly EPS?
GSK quarterly EPS is up +16.20% year-over-year
How far is GSK quarterly EPS from its all-time high?
GSK quarterly EPS is currently -81.72% below its historical high of $6.28 set on March 31, 2015
How does GSK quarterly EPS rank versus sector peers?
GSK quarterly EPS is higher than 93.14% of companies in Healthcare sector
How does the analyst estimate for GSK quarterly EPS compare to its current value?
Analysts estimate GSK quarterly EPS at $1.25, +8.62% higher than the current value
When is GSK next earnings release?
The next earnings release for GSK is on
EPS Formula
EPS =
TTM EPS
$3.82$0.16+4.37%
Summary
- Current Value
- As of today, GSK TTM EPS is $3.82, up +4.37% on
- Historical Performance
- GSK TTM EPS is up +98.54% year-over-year, down -54.95% over the past 3 years
- All-Time High Comparison
- GSK TTM EPS is currently -57.34% below its historical high of $8.96 set on
- 3-Year Low Comparison
- GSK TTM EPS is +148.81% above its 3-year low of $1.54 reached on
- Sector Comparison
- GSK TTM EPS is higher than 92.96% of companies in Healthcare sector
- Analyst Estimate
- Analysts estimate GSK TTM EPS at $4.13, +8.12% higher than the current value
- Upcoming Earnings
- The next earnings release for GSK is on
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EPS | $3.82 | +4.4% | +98.5% | -55.0% | +13.4% | |
| Quarterly EPS | $1.15 | +177.5% | +16.2% | +29.6% | +56.5% | |
| Annual EPS | $3.66 | – | +130.3% | -59.4% | +0.0% | |
| Price | $50.67 | -2.7% | +31.1% | +44.1% | +24.7% | |
| TTM Revenue | $43.93B | +1.9% | +9.2% | +25.5% | +3.6% | |
| PE Ratio | 13.25 | -6.8% | -34.0% | +220.1% | +10.1% | |
| TTM Net Income | $8.53B | +3.0% | +85.4% | +48.7% | +10.5% | |
| TTM Gross Profit | $31.99B | +2.3% | +10.7% | +30.2% | +12.0% | |
| Shares Outstanding | 2.00B | – | -1.9% | -1.1% | +0.1% |
TTM EPS Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $3.82 | at high | |
| 3Y | $8.96 | -57.3% | |
| 5Y | $8.96 | -57.3% | |
| All | $8.96 | -57.3% |
TTM EPS Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.93 | N/A | +98.5% |
| 3Y | $1.54 | +148.8% | |
| 5Y | $1.54 | +148.8% | |
| All | $0.00 | N/A |
TTM EPS History
FAQ
What is the current TTM EPS of GSK?
As of today, GSK TTM EPS is $3.82
What is GSK TTM EPS most recent change?
GSK TTM EPS was up +4.37% on March 31, 2026
What is 1-year change in GSK TTM EPS?
GSK TTM EPS is up +98.54% year-over-year
How far is GSK TTM EPS from its all-time high?
GSK TTM EPS is currently -57.34% below its historical high of $8.96 set on June 30, 2023
How does GSK TTM EPS rank versus sector peers?
GSK TTM EPS is higher than 92.96% of companies in Healthcare sector
How does the analyst estimate for GSK TTM EPS compare to its current value?
Analysts estimate GSK TTM EPS at $4.13, +8.12% higher than the current value
When is GSK next earnings release?
The next earnings release for GSK is on
EPS Formula
EPS =
Data Sources & References
- GSK Official Website www.gsk.com
- GSK Profile on Yahoo Finance finance.yahoo.com/quote/GSK
- GSK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gsk